1. Home
  2. RCG vs LSTA Comparison

RCG vs LSTA Comparison

Compare RCG & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RCG

RENN Fund Inc

SELL

Current Price

$2.57

Market Cap

18.0M

Sector

Finance

ML Signal

SELL

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$2.04

Market Cap

20.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCG
LSTA
Founded
1994
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Misc Health and Biotechnology Services
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.0M
20.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RCG
LSTA
Price
$2.57
$2.04
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
5.9K
32.8K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
0.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,070,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.52
$1.81
52 Week High
$1.90
$4.20

Technical Indicators

Market Signals
Indicator
RCG
LSTA
Relative Strength Index (RSI) 48.85 43.33
Support Level $2.50 $1.85
Resistance Level $2.60 $2.17
Average True Range (ATR) 0.07 0.17
MACD -0.01 0.01
Stochastic Oscillator 48.00 47.76

Price Performance

Historical Comparison
RCG
LSTA

About RCG RENN Fund Inc

RENN Fund Inc is active in the financial services domain. It is a a registered, non-diversified, closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, oil and gas, medical chemicals, botanical products, etc.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: